To include your compound in the COVID-19 Resource Center, submit it here.

In line Ocaliva sales welcomed by investors

On Wednesday, Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) reported Ocaliva obeticholic acid sales that were in line with analysts' expectations despite communications from FDA in September concerning adverse events associated

Read the full 283 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE